Medtronic upgraded by Morgan Stanley with a new price target
$MDT
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Morgan Stanley upgraded Medtronic from Equal-Weight to Overweight and set a new price target of $104.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/16/2025 | $110.00 | Outperform | Leerink Partners |
| 3/4/2025 | $92.00 → $107.00 | Neutral → Buy | Citigroup |
| 10/10/2024 | $98.00 → $105.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 8/21/2024 | $92.00 → $94.00 | Perform | Oppenheimer |
| 8/15/2024 | $76.00 → $90.00 | Sell → Neutral | UBS |
| 8/14/2024 | $100.00 → $85.00 | Buy → Hold | Stifel |
| 5/30/2024 | $83.00 | Sell | Goldman |
| 7/19/2023 | $90.00 | Neutral | Robert W. Baird |